Conceding findings, engineered MSC to express HSV/TK (MSC-HSV/TK) could phosphorylate GCV to its toxic metabolites and consequently induce tumor regression in human tumors (Kenarkoohi et al., 2020). The gene discussed is TKT; the disease is neoplasm.